We develop, manufacture and market both implantable and disposable medical devices used in the treatment of neurovascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. We believe our products provide a safe and reliable alternative to more invasive neurosurgical procedures for treating aneurysms. Our proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. We also sell accessory devices and products used in neurovascular procedures.
When was Micrus incorporated, and in which state?
We were incorporated in Delaware in 1996, and began commercial sales of our microcoil products in 2000.
How many people does Micrus employ?
Micrus currently employs 287 people.
What is Micrus' fiscal year end?
March 31.
On which exchange does Micrus trade and what is the symbol?
Micrus is listed on the NASDAQ National Market, under the trading symbol MEND.
When did Micrus become public?
The Company announced its initial public offering (IPO) of 3.25 million shares of the Company's common stock at $11.00 per share on June 15, 2005.
Who were the underwriters?
A.G. Edwards & Sons, Inc. and Needham & Company, LLC were the lead underwriters.
How many shares are outstanding?
As of November 1, 2007, there were 15,500,718 shares of common stock outstanding.
Does Micrus issue dividends on its common stock?
Micrus does not currently issue dividends.
Does Micrus have a direct stock purchase plan?
Micrus does not currently have a direct stock purchase plan.
Who are Micrus' independent auditors?
PricewaterhouseCoopers LLP
Who is Micrus' stock transfer agent?
American Stock Transfer and Trust Company
59 Maiden Lane, Plaza Level
New York, NY 10038
Phone: (800) 937-5449
Fax: (718) 236-2641 www.amstock.com
Who is Micrus' legal counsel?
Orrick, Herrington & Sutcliffe LLP
1000 Marsh Road
Menlo Park, CA 94025-1015
Phone: 650-614-7682
Fax: 650-614-7401 www.orrick.com
Where is Micrus' headquarters?
We are located in the San Francisco Bay Area. Our address is:
821 Fox Lane
San Jose, CA 95131
Do you have another question that hasn't been answered?
Please submit your question using the form below. Fields marked with an * are required.
show all
hide all